MMJ Cannabis compounds may limit Stroke Damage


Researchers at the University of Nottingham conducted a meta-analysis of experimental studies into cannabinoids; chemicals related to those found in cannabis, some of which also occur naturally in the body. The findings showed that the compounds could reduce the size of stroke and improve neurological function.

Cannabinoids can be classified into those found naturally in the body (endocannabinoids), those made artificially (synthetic cannabinoids) or those derived from extracts from the plant cannabis sativa (phytocannabinoids).

The research announced at the annual UK Stroke Forum indicates that all three classes of cannabinoid could be effective in shrinking the area of the brain affected by stroke and in recovering neurological function.

Dr. Tim England, Honorary Consultant Stroke Physician at the University of Nottingham and Royal Derby Hospital led the study. He said: "This meta-analysis of pre-clinical stroke studies provides valuable information on the existing, and importantly, missing data on the use of cannabinoids as a potential treatment for stroke patients. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial."

Read More: MedicalXPress

Freeleaf The World’s First and Only Flavored Odorless Smokable Cannabis Flowe

Reviews and Profiles

Toss the Torch Get The Dipper by Dip Devices

Toss the Torch Get The Dipper by Dip Devices
10% OFF with Code CJ10

Popular Posts Last 30 Days